Chang‐Hui Ge

1.7k total citations
54 papers, 1.2k citations indexed

About

Chang‐Hui Ge is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Chang‐Hui Ge has authored 54 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Surgery. Recurrent topics in Chang‐Hui Ge's work include Liver physiology and pathology (8 papers), Effects of Radiation Exposure (8 papers) and Pancreatic function and diabetes (5 papers). Chang‐Hui Ge is often cited by papers focused on Liver physiology and pathology (8 papers), Effects of Radiation Exposure (8 papers) and Pancreatic function and diabetes (5 papers). Chang‐Hui Ge collaborates with scholars based in China and United States. Chang‐Hui Ge's co-authors include Chang‐Yan Li, Yi‐Qun Zhan, Miao Yu, Xiaoming Yang, Wang‐Xiang Xu, Rong‐Hua Yin, Liujun Tang, Jianhong Zhang, Wei Li and Hui Chen and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Chang‐Hui Ge

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chang‐Hui Ge China 19 795 193 191 177 131 54 1.2k
Chang‐Yan Li China 21 905 1.1× 206 1.1× 222 1.2× 186 1.1× 152 1.2× 81 1.5k
Yi‐Qun Zhan China 18 748 0.9× 176 0.9× 196 1.0× 146 0.8× 143 1.1× 51 1.2k
Chun Wang China 21 774 1.0× 216 1.1× 262 1.4× 354 2.0× 90 0.7× 95 1.5k
Wenbin Chen China 20 798 1.0× 136 0.7× 402 2.1× 241 1.4× 109 0.8× 57 1.5k
Bing Xu China 20 913 1.1× 240 1.2× 293 1.5× 340 1.9× 76 0.6× 43 1.4k
Lu Gao China 20 599 0.8× 241 1.2× 171 0.9× 135 0.8× 183 1.4× 63 1.2k
Haibin Zhang China 19 677 0.9× 128 0.7× 125 0.7× 399 2.3× 115 0.9× 55 1.2k
Laura M. López‐Sánchez Spain 19 489 0.6× 97 0.5× 197 1.0× 188 1.1× 122 0.9× 34 1.1k
Hongtao Lu China 18 747 0.9× 375 1.9× 146 0.8× 246 1.4× 195 1.5× 65 1.6k
Yu Gu China 21 778 1.0× 137 0.7× 215 1.1× 250 1.4× 98 0.7× 61 1.3k

Countries citing papers authored by Chang‐Hui Ge

Since Specialization
Citations

This map shows the geographic impact of Chang‐Hui Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Hui Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Hui Ge more than expected).

Fields of papers citing papers by Chang‐Hui Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Hui Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Hui Ge. The network helps show where Chang‐Hui Ge may publish in the future.

Co-authorship network of co-authors of Chang‐Hui Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Hui Ge. A scholar is included among the top collaborators of Chang‐Hui Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Hui Ge. Chang‐Hui Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Qiong, Kexin Ding, Jie Zhu, et al.. (2024). Toll-like Receptor Agonist CBLB502 Protects Against Radiation-induced Intestinal Injury in Mice. In Vivo. 38(4). 1636–1648.
3.
Wang, Qiong, et al.. (2023). Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice. In Vivo. 37(5). 2044–2056. 2 indexed citations
4.
Chen, Lu, Chang‐Hui Ge, Xiuxue Feng, et al.. (2022). Identification of Combinations of Plasma lncRNAs and mRNAs as Potential Biomarkers for Precursor Lesions and Early Gastric Cancer. Journal of Oncology. 2022. 1–13. 4 indexed citations
5.
Wang, Xiaohan, Chang‐Yan Li, Xian Liu, et al.. (2020). GPS2 promotes erythroid differentiation by control of the stability of EKLF protein. Blood. 135(25). 2302–2315. 13 indexed citations
6.
Zhang, Wen, Ting Wang, Yating Li, et al.. (2020). NLRP3 is dispensable for d-galactosamine/lipopolysaccharide-induced acute liver failure. Biochemical and Biophysical Research Communications. 533(4). 1184–1190. 5 indexed citations
7.
8.
Xiao, Yang, Wen Zhang, Yu Wang, et al.. (2019). ABRO1 promotes NLRP3 inflammasome activation through regulation of NLRP3 deubiquitination. The EMBO Journal. 38(6). 126 indexed citations
9.
Fu, Hanjiang, Fei Su, Jie Zhu, Xiaofei Zheng, & Chang‐Hui Ge. (2019). Effect of simulated microgravity and ionizing radiation on expression profiles of miRNA, lncRNA, and mRNA in human lymphoblastoid cells. Life Sciences in Space Research. 24. 1–8. 20 indexed citations
10.
Bai, Hao, Lei Wang, Quanhai Zhang, et al.. (2018). CBLB502, a Toll-like receptor 5 agonist, offers protection against radiation-induced male reproductive system damage in mice†. Biology of Reproduction. 100(1). 281–291. 27 indexed citations
11.
Xu, Yang, Chang‐Hui Ge, Yan Gao, et al.. (2016). CBLB502 administration protects gut mucosal tissue in ulcerative colitis by inhibiting inflammation. Annals of Translational Medicine. 4(16). 301–301. 15 indexed citations
12.
Li, Weiguang, Chang‐Hui Ge, Yang Liu, et al.. (2015). CBLB502, an agonist of Toll-like receptor 5, has antioxidant and scavenging free radicals activities in vitro. International Journal of Biological Macromolecules. 82. 97–103. 25 indexed citations
13.
Zhao, Long, Hui Chen, Yi‐Qun Zhan, et al.. (2014). Serine 249 phosphorylation by ATM protein kinase regulates hepatocyte nuclear factor-1α transactivation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1839(7). 604–620. 6 indexed citations
14.
Huang, Rui, Long Zhao, Hui Chen, et al.. (2014). Megakaryocytic Differentiation of K562 Cells Induced by PMA Reduced the Activity of Respiratory Chain Complex IV. PLoS ONE. 9(5). e96246–e96246. 43 indexed citations
15.
Kong, Xiang-Zhen, Rong‐Hua Yin, Hongmei Ning, et al.. (2014). Effects of THAP11 on Erythroid Differentiation and Megakaryocytic Differentiation of K562 Cells. PLoS ONE. 9(3). e91557–e91557. 9 indexed citations
16.
Yu, Miao, Xiaohui Wang, Chang‐Yan Li, et al.. (2013). 14-3-3ζ interacts with hepatocyte nuclear factor 1α and enhances its DNA binding and transcriptional activation. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1829(9). 970–979. 3 indexed citations
17.
Yin, Rong‐Hua, Xiang-Zhen Kong, Tong Zhang, et al.. (2012). THAP11, a novel binding protein of PCBP1, negatively regulates CD44 alternative splicing and cell invasion in a human hepatoma cell line. FEBS Letters. 586(10). 1431–1438. 29 indexed citations
18.
Liu, Jing, Xiang-Zhen Kong, Shouguo Zhang, et al.. (2012). Induction of activation of the antioxidant response element and stabilization of Nrf2 by 3-(3-pyridylmethylidene)-2-indolinone (PMID) confers protection against oxidative stress-induced cell death. Toxicology and Applied Pharmacology. 259(2). 227–235. 18 indexed citations
19.
Cao, Mengmeng, Wang‐Xiang Xu, Chang‐Yan Li, et al.. (2011). Hepassocin regulates cell proliferation of the human hepatic cells L02 and hepatocarcinoma cells through different mechanisms. Journal of Cellular Biochemistry. 112(10). 2882–2890. 28 indexed citations
20.
Yu, Miao, Hui Li, Qiongming Liu, et al.. (2011). Nuclear factor p65 interacts with Keap1 to repress the Nrf2-ARE pathway. Cellular Signalling. 23(5). 883–892. 275 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chang‐Yan Li Breakdown of academic impact, for papers by Yi‐Qun Zhan Breakdown of academic impact, for papers by Chun Wang Breakdown of academic impact, for papers by Wenbin Chen Breakdown of academic impact, for papers by Bing Xu Breakdown of academic impact, for papers by Lu Gao Breakdown of academic impact, for papers by Haibin Zhang Breakdown of academic impact, for papers by Laura M. López‐Sánchez Breakdown of academic impact, for papers by Hongtao Lu Breakdown of academic impact, for papers by Yu Gu
Rankless by CCL
2026